1. Home
  2. FGEN vs GIFT Comparison

FGEN vs GIFT Comparison

Compare FGEN & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • GIFT
  • Stock Information
  • Founded
  • FGEN 1993
  • GIFT 1999
  • Country
  • FGEN United States
  • GIFT United States
  • Employees
  • FGEN N/A
  • GIFT N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • GIFT Catalog/Specialty Distribution
  • Sector
  • FGEN Health Care
  • GIFT Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • GIFT Nasdaq
  • Market Cap
  • FGEN 34.5M
  • GIFT 37.1M
  • IPO Year
  • FGEN 2014
  • GIFT N/A
  • Fundamental
  • Price
  • FGEN $0.57
  • GIFT $1.03
  • Analyst Decision
  • FGEN
  • GIFT
  • Analyst Count
  • FGEN 0
  • GIFT 0
  • Target Price
  • FGEN N/A
  • GIFT N/A
  • AVG Volume (30 Days)
  • FGEN 1.7M
  • GIFT 87.0K
  • Earning Date
  • FGEN 02-24-2025
  • GIFT 02-15-2025
  • Dividend Yield
  • FGEN N/A
  • GIFT N/A
  • EPS Growth
  • FGEN N/A
  • GIFT N/A
  • EPS
  • FGEN N/A
  • GIFT N/A
  • Revenue
  • FGEN $180,015,000.00
  • GIFT $86,439,146.00
  • Revenue This Year
  • FGEN $22.05
  • GIFT N/A
  • Revenue Next Year
  • FGEN N/A
  • GIFT N/A
  • P/E Ratio
  • FGEN N/A
  • GIFT N/A
  • Revenue Growth
  • FGEN 16.15
  • GIFT N/A
  • 52 Week Low
  • FGEN $0.18
  • GIFT $0.50
  • 52 Week High
  • FGEN $2.93
  • GIFT $4.55
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 57.36
  • GIFT N/A
  • Support Level
  • FGEN $0.51
  • GIFT N/A
  • Resistance Level
  • FGEN $0.76
  • GIFT N/A
  • Average True Range (ATR)
  • FGEN 0.09
  • GIFT 0.00
  • MACD
  • FGEN -0.00
  • GIFT 0.00
  • Stochastic Oscillator
  • FGEN 33.26
  • GIFT 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About GIFT RDE Inc. Common Stock

Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.

Share on Social Networks: